Wordt geladen...
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
BACKGROUND: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of “clinically...
Bewaard in:
| Gepubliceerd in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400232/ https://ncbi.nlm.nih.gov/pubmed/30880943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S196383 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|